Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 20631089)

1.

Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5.

Alcaraz-Estrada SL, Manzano MI, Del Angel RM, Levis R, Padmanabhan R.

J Gen Virol. 2010 Nov;91(Pt 11):2713-8. doi: 10.1099/vir.0.024083-0. Epub 2010 Jul 14.

2.

Mutagenesis of the dengue virus type 2 NS5 methyltransferase domain.

Kroschewski H, Lim SP, Butcher RE, Yap TL, Lescar J, Wright PJ, Vasudevan SG, Davidson AD.

J Biol Chem. 2008 Jul 11;283(28):19410-21. doi: 10.1074/jbc.M800613200. Epub 2008 May 9.

3.
4.

Construction of self-replicating subgenomic dengue virus 4 (DENV4) replicon.

Alcaraz-Estrada SL, Del Angel R, Padmanabhan R.

Methods Mol Biol. 2014;1138:131-50. doi: 10.1007/978-1-4939-0348-1_9.

PMID:
24696335
5.
6.
7.
8.

Substitution of NS5 N-terminal domain of dengue virus type 2 RNA with type 4 domain caused impaired replication and emergence of adaptive mutants with enhanced fitness.

Teramoto T, Boonyasuppayakorn S, Handley M, Choi KH, Padmanabhan R.

J Biol Chem. 2014 Aug 8;289(32):22385-400. doi: 10.1074/jbc.M114.584466. Epub 2014 Jun 5.

PMID:
24904061
9.

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.

Ng CY, Gu F, Phong WY, Chen YL, Lim SP, Davidson A, Vasudevan SG.

Antiviral Res. 2007 Dec;76(3):222-31. Epub 2007 Jul 26.

PMID:
17662475
10.

A high-throughput assay using dengue-1 virus-like particles for drug discovery.

Qing M, Liu W, Yuan Z, Gu F, Shi PY.

Antiviral Res. 2010 May;86(2):163-71. doi: 10.1016/j.antiviral.2010.02.313. Epub 2010 Feb 12.

PMID:
20153777
12.

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.

Blaney JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR, Whitehead SS.

Virology. 2002 Aug 15;300(1):125-39.

13.
14.

Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein.

Tajima S, Takasaki T, Kurane I.

Virus Genes. 2008 Apr;36(2):323-9. doi: 10.1007/s11262-008-0211-7. Epub 2008 Feb 21.

PMID:
18288598
15.

Development and characterization of a stable luciferase dengue virus for high-throughput screening.

Zou G, Xu HY, Qing M, Wang QY, Shi PY.

Antiviral Res. 2011 Jul;91(1):11-9. doi: 10.1016/j.antiviral.2011.05.001. Epub 2011 May 7.

PMID:
21575658
16.

Trans-complementation of HCV replication by non-structural protein 5A.

Tong X, Malcolm BA.

Virus Res. 2006 Feb;115(2):122-30. Epub 2005 Sep 15.

PMID:
16146661
18.

2'-O methylation of internal adenosine by flavivirus NS5 methyltransferase.

Dong H, Chang DC, Hua MH, Lim SP, Chionh YH, Hia F, Lee YH, Kukkaro P, Lok SM, Dedon PC, Shi PY.

PLoS Pathog. 2012;8(4):e1002642. doi: 10.1371/journal.ppat.1002642. Epub 2012 Apr 5.

19.

Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes.

Pu SY, Wu RH, Yang CC, Jao TM, Tsai MH, Wang JC, Lin HM, Chao YS, Yueh A.

J Virol. 2011 Mar;85(6):2927-41. doi: 10.1128/JVI.01986-10. Epub 2011 Jan 12.

20.

Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.

Alcaraz-Estrada SL, Reichert ED, Padmanabhan R.

Methods Mol Biol. 2013;1030:283-99. doi: 10.1007/978-1-62703-484-5_22.

PMID:
23821276
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk